ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Affinivax, Astellas’ pneumococcal vaccine wins breakthrough therapy status
July 16, 2021Affinivax and Astellas’ pneumococcal vaccine candidate ASP3772 has been granted a breakthrough therapy designation by the US Food and Drug Administration (FDA), the companies announced earlier this week. -
Affinivax secures $226m in Series C financing to boost MAPS vaccine pipeline
January 12, 2021Clinical-stage biopharmaceutical company Affinivax has secured $226m in Series C financing to advance the development of new vaccines with its multiple antigen presenting system (MAPS) platform. -
Astellas and Affinivax’s novel pneumococcal vaccine enters human testing
February 24, 2019About two years ago, Astellas licensed a novel pneumococcal vaccine technology from Affinivax with eyes on Pfizer’s Prevnar 13. Now, the pair has officially entered human testing.
Pharma Sources Insight January 2025
